• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

XOMA Royalty Corporation - 8.625% Series A Cumulative Perpetual Preferred Stock (NQ:XOMAP)

26.33 UNCHANGED
Streaming Delayed Price Updated: 3:40 PM EST, Jan 20, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about XOMA Royalty Corporation - 8.625% Series A Cumulative Perpetual Preferred Stock

< Previous 1 2 3 Next >
News headline image
XOMA Royalty Announces CFO Transition
January 12, 2026
From XOMA Royalty Corporation
Via GlobeNewswire
News headline image
XOMA Royalty and Takeda Execute Strategic Royalty Sharing Transaction and Amend Existing Agreement for Mezagitamab
December 30, 2025
From XOMA Royalty Corporation
Via GlobeNewswire
News headline image
XOMA Royalty Declares Quarterly Preferred Stock Dividends
December 22, 2025
From XOMA Royalty Corporation
Via GlobeNewswire
News headline image
XOMA Royalty Announces Closing of Transaction to Acquire Mural Oncology plc
December 05, 2025
From XOMA Royalty Corporation
Via GlobeNewswire
News headline image
XOMA Royalty Announces Closing of Transactions to Acquire LAVA Therapeutics N.V.
November 21, 2025
From XOMA Royalty Corporation
Via GlobeNewswire
News headline image
XOMA Royalty Reports Third Quarter and Year to Date 2025 Financial Results and Highlights Recent Business Achievements
November 12, 2025
From XOMA Royalty Corporation
Via GlobeNewswire
News headline image
XOMA Royalty and LAVA Therapeutics Announce Amendment to Purchase Agreement
October 17, 2025
From XOMA Royalty Corporation; LAVA Therapeutics N.V.
Via GlobeNewswire
News headline image
XOMA Royalty Extends Tender Offer to Acquire LAVA Therapeutics N.V.
October 02, 2025
From XOMA Royalty Corporation; LAVA Therapeutics
Via GlobeNewswire
News headline image
XOMA Royalty Declares Quarterly Preferred Stock Dividends
September 22, 2025
From XOMA Royalty Corporation
Via GlobeNewswire
News headline image
XOMA Royalty Announces Closing of Tender Offer for HilleVax, Inc.
September 17, 2025
HilleVax Stockholders Received $1.95 Per Share in Cash Plus a Contingent Value Right 
From XOMA Royalty Corporation
Via GlobeNewswire
News headline image
XOMA Royalty to Present at H.C. Wainwright 27th Annual Global Investment Conference
September 03, 2025
From XOMA Royalty Corporation
Via GlobeNewswire
News headline image
Mural Oncology Announces Entry into Agreement to be Acquired by XRA 5 Corp., a wholly owned subsidiary of XOMA Royalty for between $2.035 and $2.24 in Cash per Share
August 20, 2025
From XOMA Royalty Corporation
Via GlobeNewswire
News headline image
XOMA Royalty Reports Second Quarter and Year to Date 2025 Financial Results and Highlights Recent Business Achievements
August 13, 2025
From XOMA Royalty Corporation
Via GlobeNewswire
News headline image
XOMA Royalty Announces Closing of Tender Offer for Turnstone Biologics
August 11, 2025
From XOMA Royalty Corporation
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
August 07, 2025
 
Via Benzinga
News headline image
XOMA Royalty Enters into Agreement to Acquire LAVA Therapeutics for Between $1.16 and $1.24 Per Share in Cash, Plus a Contingent Value Right
August 04, 2025
XOMA Royalty adds milestone and royalty economics associated with two partnered assets 
From XOMA Royalty Corporation; LAVA Therapeutics N.V.
Via GlobeNewswire
News headline image
HilleVax Enters into a Definitive Agreement to be Acquired by XOMA Royalty for $1.95 in Cash per Share Plus a Contingent Value Right
August 04, 2025
From XOMA Royalty Corporation
Via GlobeNewswire
News headline image
Turnstone Biologics Corp. Enters into Agreement to be Acquired by XOMA Royalty Corporation for $0.34 in Cash Per Share Plus a Contingent Value Right
June 27, 2025
From XOMA Royalty Corporation; Turnstone Biologics Corp.
Via GlobeNewswire
News headline image
XOMA Royalty Declares Quarterly Preferred Stock Dividends
June 18, 2025
From XOMA Royalty Corporation
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
June 11, 2025
 
Via Benzinga
News headline image
XOMA Royalty Purchases Mezagitamab Royalty and Milestone Rights Held by BioInvent International for up to USD $30 Million
May 27, 2025
From XOMA Royalty Corporation; BioInvent
Via GlobeNewswire
News headline image
XOMA Royalty Reports First Quarter 2025 Financial Results and Highlights Business Achievements
May 13, 2025
From XOMA Royalty Corporation
Via GlobeNewswire
News headline image
XOMA Royalty to Present at H.C. Wainwright 1st Annual Royalty Company Virtual Conference
May 07, 2025
From XOMA Royalty Corporation
Via GlobeNewswire
News headline image
XOMA Royalty Completes Sale of Kinnate Pipeline Assets
April 14, 2025
From XOMA Royalty Corporation
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
April 04, 2025
 
Via Benzinga
News headline image
XOMA Royalty to Present at Jones Healthcare and Technology Innovation Conference
April 02, 2025
From XOMA Royalty Corporation
Via GlobeNewswire
News headline image
XOMA Royalty Declares Quarterly Preferred Stock Dividends
March 20, 2025
From XOMA Royalty Corporation
Via GlobeNewswire
News headline image
XOMA Royalty Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Business Achievements
March 17, 2025
From XOMA Royalty Corporation
Via GlobeNewswire
News headline image
XOMA Royalty to Present at Investor Conferences in March
February 24, 2025
From XOMA Royalty Corporation
Via GlobeNewswire
News headline image
XOMA Royalty to Present at Oppenheimer 35th Annual Healthcare Life Sciences Conference
February 04, 2025
From XOMA Royalty Corporation
Via GlobeNewswire
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap